Skip to main content
logo
Asston Pharmaceuticals Limited (BOM:544445)
India flag India · Delayed Price · Currency is INR
99.75
+2.45 (2.52%)
At close: Sep 25, 2026

Asston Pharmaceuticals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
254.69254.69250.39155.8665.3895.99
Revenue Growth
4.02%1.72%60.65%138.39%-31.89%19.47%
Gross Profit
80.5680.56108.9658.3231.8919.25
Operating Income
-8.4-8.462.132.414.8-3.64
Net Income
38.6538.6538.5313.610.571.11
Earnings Per Share
4.924.926.142.371.8911.62
EPS Growth
30.70%-19.97%159.22%25.61%-83.76%1.45%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
12.9112.911.990.061.241.37
Total Debt
51.0851.0872.5768.252.4533.1
Net Cash (Debt)
-38.17-38.17-70.58-68.14-51.21-31.73
Net Cash Growth
------
Net Cash Per Share
-4.86-4.86-11.25-12.17-9.15-333.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-101.8-101.8-0.25-38-3.16-11.86
Capital Expenditures
-100.63-100.63--0.1-2.51-0.02
Free Cash Flow
-202.42-202.42-0.25-38.11-5.67-11.89
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
31.63%31.63%43.51%37.42%48.77%20.05%
Operating Margin
-3.30%-3.30%24.80%20.79%22.63%-3.79%
Pretax Margin
18.04%18.04%20.03%11.66%21.61%1.66%
Profit Margin
15.18%15.18%15.39%8.73%16.16%1.15%
FCF Margin
-79.48%-79.48%-0.10%-24.45%-8.67%-12.38%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
20.2916.08----
PS Ratio
4.282.44----